Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
It's never too early to start thinking about retirement. Learn when and how to begin planning for a secure financial future.
13,633 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Seoul lawmakers push to scrap the 22% crypto gains tax slated for 2025, arguing the policy is unfair to everyday inve...
Lands' End is at a crossroads as it approaches 2025 earnings. This guide breaks down what to watch, how to model pote...
When oil climbs past $100, some stocks tend to move higher more often than not. This guide breaks down five names tha...
SanDisk moved down about 5% after reporting strong Q4 results, fueling a sharp debate on whether the AI-led rally in ...
Deutsche Bank revealed a $30 billion private credit exposure, roughly 2.1% of its asset base, triggering a stock pull...
With $1,000 in hand, your goal is steady income and growing wealth. This guide shows how to identify the ultimate div...
As major retailers push Beyond Meat into the frozen aisle, investors debate the stock's trajectory. This guide breaks...
Monero's XMR remains in a tight range around the mid-$180s as liquidity thins. Analysts say the trapped setup could f...
Two concrete signals could shape the S&P 500 this week in the wake of Signet Jewelers' earnings. This guide explains ...
OpenAI’s IPO-style risk disclosure confirms Microsoft’s central role in its operations, signaling potential leverage ...
Big-cap U.S. stocks are trading at more attractive levels after a year of resilience and rising macro uncertainty. An...